https://www.ajmc.com/view/posters-present-improved-survival-safety-and-efficacy-results-in-imm-101-lab-vaccines
0
0
44 words
0
Comments
Researchers provide progression-free survival outcomes for a pancreatic cancer vaccine and safety and efficacy results for a peptide vaccine alone or in combination with pembrolizumab.
You are the first to view
Create an account or login to join the discussion